Surescripts Standardizes on Splunk Software to Target Healthcare Fraud
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/21/2026
- Wall St indexes advance with boost from chips, Iran optimism
- Intel soars after Trump says Apple agreed to work with chipmaker on US production
- Apple CEO warns price hikes 'unavoidable' as chip costs bite - WSJ
- Wall Street scrambles to lift Micron price targets ahead of earnings
- SanDisk and Micron surge as Apple confirms memory price pass-through
- Zelenskiy: best guarantee of Europe's future is fast-track EU membership for Ukraine
- Needham Starts NeoVolta (NEOV) at Buy
- Fed: Nine Of 18 FOMC Participants Pencil In 2026 Rate Hike
- Delta Air Lines (DAL) Raises Quarterly Dividend 14.7% to $0.2150; 1% Yield
- Oil rises 1% on US-Iran deal doubts; IEA warns of supply glut
Cantor Fitzgerald Remains Bullish Ahead of Splunk's (SPLK) 1Q Report
May 21, 2015 8:47 AM EDTCantor Fitzgerald maintains a Buy rating and $90 price target on Splunk (NASDAQ: SPLK) leading up to its 1Q16 results. Analyst Brian White believes that Splunk will at least meet his 1Q revenue estimate of $120.9m, and EPS estimate of ($0.04). Splunk is scheduled to report 1Q earnings on May... More
